U.S. Physical Therapy shares slipped about 1.5% today, yet the earnings story reads more like a sharp reset than a setback. After two loss making quarters, the company swung back to profit in Q2 with basic earnings per share of US$0.66 and net income of US$9.9m on revenue of US$211.9m. For a stock that has climbed strongly over the past three months and still carries a very high trailing P/E, the modest pullback suggests investors are wrestling with how durable this profit recovery really is.

Love the sharp profit rebound at U.S. Physical Therapy but concerned about paying up for a stock with a very high trailing P/E and recent losses still fresh in mind? Check out 77 resilient stocks with low risk scores for a mix of steadier profiles and more resilient risk scores.

Q2 2026 Earnings Summary

• Revenue, Q2 2026 vs. Q2 2025: US$211.9m vs. US$195.3m (higher year on year)
• Net Income, Q2 2026 vs. Q2 2025: US$9.9m vs. US$8.8m (higher year on year)
• Basic EPS, Q2 2026 vs. Q2 2025: US$0.66 vs. US$0.58 (higher year on year)
• Trailing 12 Month Net Profit Margin, Q2 2026 vs. prior year: 1.8% vs. 4.8% (margin compressed over the year)

Prefer clean visuals instead of scanning through more earnings tables and footnotes? See U.S. Physical Therapy's full financial picture with an at a glance view of its valuation in the company report for U.S. Physical Therapy.

U.S. Physical Therapy bull case gets partial support

The upbeat story on U.S. Physical Therapy is that record clinic volumes, new employer programs, and tech enabled efficiencies can steadily lift earnings. Q2 gives some support to that idea. Revenue and net income were both higher than a year ago and the company moved from two loss making quarters to a profit of US$9.9m and EPS of US$0.66. That is a tangible step toward the earnings recovery bulls want to see. The recent acquisition of a majority stake in 12 clinics and an expanded footprint in 45 states also lines up with the roll up and partnership thesis. However, the trailing 12 month net margin sits at 1.8% compared with 4.8% a year earlier. That signals that cost efficiency tools and higher reimbursement markets are not yet visible in sustained margin improvement.

Bearish concerns on margins and risk still present

The cautious view is that reimbursement pressure, staffing costs, and richer competition keep squeezing U.S. Physical Therapy even as it grows. The latest numbers have some backing for that view. While Q2 profit returned, the trailing net margin has compressed from 4.8% to 1.8%. That suggests recent Medicare and payer pressures are still flowing through earnings. Bulls point to AI assisted documentation and semi virtual front desks, yet the lower trailing margin shows these initiatives have not yet offset wage and reimbursement headwinds at scale. The stock has also given back around 1.5% today and is down roughly 4.6% over 7 days after a strong 90 day run. That pattern fits a market rechecking earlier optimism while risks around policy, labor and digital competitors remain unresolved.

Compare U.S. Physical Therapy’s profit rebound and margin pressure with where institutional expectations actually sit by checking whether analysts are leaning into a sustained recovery or fading the story in their targets with the consensus price target analysis for U.S. Physical Therapy.

Stay Ahead Of Your Next Move

If U.S. Physical Therapy’s sharp swing back to profit has your attention but the high trailing P/E and margin pressure keep you cautious, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how the thesis develops. Once you decide to take a position, use the Portfolio Command Center to cut through noise and focus on essential updates that matter to your holdings. For a broader view on how other investors are thinking about U.S. Physical Therapy and similar stocks, tap into the Community and compare different perspectives. This helps you surface potential catalysts and risks earlier so you can stay ahead of the market.

Seeking Alternatives Beyond U.S. Physical Therapy?

Fresh stock ideas can move quickly from under the radar to full breakout. Screen for momentum while it matters and before the crowd catches up. Get in early.

• Spot resilient compounding stories that aim to hold up when sentiment cools by scanning the 77 resilient stocks with low risk scores curated for stronger balance sheets and steadier price behavior.
• Hunt for future income engines with strong yields that markets may be underpricing right now by reviewing the hand picked 8 dividend fortresses.
• Chase early trends in infrastructure behind the AI boom before valuations potentially run away by checking the curated 56 AI infrastructure stocks list.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.